Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Arenas MD, Malek T, Gil MT et al (2010) Challenge of phosphorus control in hemodialysis patients: a problem of adherence? J Nephrol 23:525–534
2. Arenas MD, Rebollo P, Malek T et al (2010) A comparative study of 2 new phosphate binders (sevelamer and lanthanum carbonate) in routine clinical practice. J Nephrol 23:683–692
3. Block GA, Brillhart SL, Persky MS et al (2010) Efficacy and safety of SBR759, a new iron-based phosphate binder. Kidney Int 77:897–903
4. Block GA, Fishbane S, Rodriguez M et al (2015) A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3–5. Am J Kidney Dis 65:728–736
5. Block GA, Rosenbaum DP, Leonsson-Zachrisson M et al (2016) Effect of tenapanor on interdialytic weight gain in patients on hemodialysis. Clin J Am Soc Nephrol 11:1597–1605
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In Reply;Deutsches Ärzteblatt international;2018-02-09